Page Title
Drug Development Pipeline
Liprotamase
Status
DiscontinuedTherapeutic Approach
Nutritional-GI
Liprotamase (Sollpura) is a pancreatic enzyme replacement that is not prepared from animal sources.
Status
Multiple phase 3 studies to look at the safety and effectiveness of liprotamase in people with CF ages 7 years and older have been completed.
A phase 3 study to look at the safety and effectiveness of a water-soluble formulation of liprotamase did not meet its primary endpoint. No further development is planned at this time.
Sponsor
This program is sponsored by Anthera Pharmaceuticals and partially funded by the Cystic Fibrosis Foundation. It is being conducted within the Therapeutics Development Network.

CONTACT THE CLINICAL TRIAL NAVIGATOR
Get personalized assistance and answers to your clinical trial questions.
Learn MoreSign up for clinical trial alerts
Get email updates about clinical trials that matter to you.
Explore clinical trials
Be a part of the movement transforming the future of cystic fibrosis treatment.
Learn More